Teitell MA - Search Results

1

TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.

Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. Herling M, et al. Among authors: teitell ma. Blood. 2003 Jun 15;101(12):5007-9. doi: 10.1182/blood-2002-10-3297. Epub 2003 Feb 6. Blood. 2003. PMID: 12576313 Free article.

2

High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.

Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R, Jones D. Herling M, et al. Among authors: teitell ma. Blood. 2008 Jan 1;111(1):328-37. doi: 10.1182/blood-2007-07-101519. Epub 2007 Sep 21. Blood. 2008. PMID: 17890451 Free PMC article.

3

Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.

Shen RR, Ferguson DO, Renard M, Hoyer KK, Kim U, Hao X, Alt FW, Roeder RG, Morse HC 3rd, Teitell MA. Shen RR, et al. Among authors: teitell ma. Blood. 2006 Sep 15;108(6):1991-8. doi: 10.1182/blood-2006-02-001354. Epub 2006 May 25. Blood. 2006. PMID: 16728701 Free PMC article.

4

Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.

Frank MJ, Dawson DW, Bensinger SJ, Hong JS, Knosp WM, Xu L, Balatoni CE, Allen EL, Shen RR, Bar-Sagi D, Martin GR, Teitell MA. Frank MJ, et al. Among authors: teitell ma. Blood. 2009 Mar 12;113(11):2478-87. doi: 10.1182/blood-2008-05-156943. Epub 2009 Jan 15. Blood. 2009. PMID: 19147787 Free PMC article.

5

T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation.

Hoyer KK, Herling M, Bagrintseva K, Dawson DW, French SW, Renard M, Weinger JG, Jones D, Teitell MA. Hoyer KK, et al. Among authors: teitell ma. J Immunol. 2005 Jul 15;175(2):864-73. doi: 10.4049/jimmunol.175.2.864. J Immunol. 2005. PMID: 16002684

6

TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.

Kuraishy AI, French SW, Sherman M, Herling M, Jones D, Wall R, Teitell MA. Kuraishy AI, et al. Among authors: teitell ma. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10175-80. doi: 10.1073/pnas.0704170104. Epub 2007 Jun 4. Proc Natl Acad Sci U S A. 2007. PMID: 17548807 Free PMC article.

7

A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane.

French SW, Shen RR, Koh PJ, Malone CS, Mallick P, Teitell MA. French SW, et al. Among authors: teitell ma. Biochemistry. 2002 May 21;41(20):6376-82. doi: 10.1021/bi016068o. Biochemistry. 2002. PMID: 12009899

8

Sp1 transactivation of the TCL1 oncogene.

French SW, Malone CS, Shen RR, Renard M, Henson SE, Miner MD, Wall R, Teitell MA. French SW, et al. Among authors: teitell ma. J Biol Chem. 2003 Jan 10;278(2):948-55. doi: 10.1074/jbc.M207166200. Epub 2002 Nov 5. J Biol Chem. 2003. PMID: 12421830 Free article.

9

Transdifferentiation and nuclear reprogramming in hematopoietic development and neoplasia.

French SW, Hoyer KK, Shen RR, Teitell MA. French SW, et al. Among authors: teitell ma. Immunol Rev. 2002 Sep;187:22-39. doi: 10.1034/j.1600-065x.2002.18703.x. Immunol Rev. 2002. PMID: 12366680 Review.

10

Distinct contributions of microtubule subtypes to cell membrane shape and stability.

Pelling AE, Dawson DW, Carreon DM, Christiansen JJ, Shen RR, Teitell MA, Gimzewski JK. Pelling AE, et al. Among authors: teitell ma. Nanomedicine. 2007 Mar;3(1):43-52. doi: 10.1016/j.nano.2006.11.006. Nanomedicine. 2007. PMID: 17379168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters